 | • レポートコード：QYR2104Z2522 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Ex vivo、In Vivo）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・遺伝子治療の種類別市場規模（Ex vivo、In Vivo） ・遺伝子治療の用途別市場規模（がん、単発性、感染症、循環器疾患、その他） ・遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bluebird Bio、Sangamo、Spark Therapeutics、Dimension Therapeutics、Avalanche Bio、Celladon、Vical Inc.、Advantagene） ・結論 |
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson’s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a person’s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
Market Analysis and Insights: Global Gene Therapy Market
The global Gene Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy market.
Global Gene Therapy Scope and Market Size
Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Ex vivo
In Vivo
Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ex vivo
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2016-2027)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy Industry Dynamic
2.3.1 Gene Therapy Market Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2020
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy Forecasted Market Size by Type (2022-2027)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy Market Size (2016-2027)
6.2 North America Gene Therapy Market Size by Type
6.2.1 North America Gene Therapy Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy Market Size by Type (2016-2027)
6.3 North America Gene Therapy Market Size by Application
6.3.1 North America Gene Therapy Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy Market Size by Application (2016-2027)
6.4 North America Gene Therapy Market Size by Country
6.4.1 North America Gene Therapy Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2016-2027)
7.2 Europe Gene Therapy Market Size by Type
7.2.1 Europe Gene Therapy Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy Market Size by Type (2016-2027)
7.3 Europe Gene Therapy Market Size by Application
7.3.1 Europe Gene Therapy Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy Market Size by Application (2016-2027)
7.4 Europe Gene Therapy Market Size by Country
7.4.1 Europe Gene Therapy Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy Market Size (2016-2027)
9.2 Latin America Gene Therapy Market Size by Type
9.2.1 Latin America Gene Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy Market Size by Application
9.3.1 Latin America Gene Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy Market Size by Country
9.4.1 Latin America Gene Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Business (2016-2021)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Introduction
11.2.4 Sangamo Revenue in Gene Therapy Business (2016-2021)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Business (2016-2021)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Introduction
11.6.4 Celladon Revenue in Gene Therapy Business (2016-2021)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Business (2016-2021)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Introduction
11.8.4 Advantagene Revenue in Gene Therapy Business (2016-2021)
11.8.5 Advantagene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ex vivo
Table 3. Key Players of In Vivo
Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gene Therapy Market Share by Regions (2016-2021)
Table 8. Global Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gene Therapy Market Share by Regions (2022-2027)
Table 10. Gene Therapy Market Trends
Table 11. Gene Therapy Market Drivers
Table 12. Gene Therapy Market Challenges
Table 13. Gene Therapy Market Restraints
Table 14. Global Gene Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gene Therapy Market Share by Players (2016-2021)
Table 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020)
Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy Product Solution and Service
Table 21. Date of Enter into Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gene Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gene Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bluebird Bio Company Details
Table 62. Bluebird Bio Business Overview
Table 63. Bluebird Bio Gene Therapy Product
Table 64. Bluebird Bio Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 65. Bluebird Bio Recent Development
Table 66. Sangamo Company Details
Table 67. Sangamo Business Overview
Table 68. Sangamo Gene Therapy Product
Table 69. Sangamo Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 70. Sangamo Recent Development
Table 71. Spark Therapeutics Company Details
Table 72. Spark Therapeutics Business Overview
Table 73. Spark Therapeutics Gene Therapy Product
Table 74. Spark Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 75. Spark Therapeutics Recent Development
Table 76. Dimension Therapeutics Company Details
Table 77. Dimension Therapeutics Business Overview
Table 78. Dimension Therapeutics Gene Therapy Product
Table 79. Dimension Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 80. Dimension Therapeutics Recent Development
Table 81. Avalanche Bio Company Details
Table 82. Avalanche Bio Business Overview
Table 83. Avalanche Bio Gene Therapy Product
Table 84. Avalanche Bio Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 85. Avalanche Bio Recent Development
Table 86. Celladon Company Details
Table 87. Celladon Business Overview
Table 88. Celladon Gene Therapy Product
Table 89. Celladon Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 90. Celladon Recent Development
Table 91. Vical Inc. Company Details
Table 92. Vical Inc. Business Overview
Table 93. Vical Inc. Gene Therapy Product
Table 94. Vical Inc. Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 95. Vical Inc. Recent Development
Table 96. Advantagene Company Details
Table 97. Advantagene Business Overview
Table 98. Advantagene Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
Table 99. Advantagene Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Market Share by Type: 2020 VS 2027
Figure 2. Ex vivo Features
Figure 3. In Vivo Features
Figure 4. Global Gene Therapy Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Monogenic Case Studies
Figure 7. Infectious Disease Case Studies
Figure 8. Cardiovascular Disease Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy Report Years Considered
Figure 11. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gene Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Gene Therapy Market Share by Regions (2022-2027)
Figure 15. Global Gene Therapy Market Share by Players in 2020
Figure 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2020
Figure 18. Global Gene Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Gene Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gene Therapy Market Share by Type (2016-2027)
Figure 22. North America Gene Therapy Market Share by Application (2016-2027)
Figure 23. North America Gene Therapy Market Share by Country (2016-2027)
Figure 24. United States Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Therapy Market Share by Type (2016-2027)
Figure 28. Europe Gene Therapy Market Share by Application (2016-2027)
Figure 29. Europe Gene Therapy Market Share by Country (2016-2027)
Figure 30. Germany Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gene Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gene Therapy Market Share by Region (2016-2027)
Figure 40. China Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Gene Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Gene Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gene Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gene Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bluebird Bio Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 60. Sangamo Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 61. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 62. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 63. Avalanche Bio Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 64. Celladon Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 65. Vical Inc. Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 66. Advantagene Revenue Growth Rate in Gene Therapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の心不全遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function. Market Analysis and Insights: Global Gene Therapy For Heart Failure Market The global Gene Therapy For Heart Failure market size is projected to reach US$ XX million by 2027, from …- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery Market Analysis and Insights: Global Drugs B…
- 世界のDNA遺伝子チップ市場規模・現状・予測（2021年-2027年） DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…
- 世界のFAM20B遺伝子（XYLK抗体）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global FAM20B Gene(XYLK Antibody) Market The global FAM20B Gene(XYLK Antibody) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の遺伝子サイレンシング市場規模・現状・予測（2021年-2027年） Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research.In particular, methods used to silence genes are being increasingly used to produce therapeutic…